LONDON, Sept. 22, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (LIVN.L) (LIVN.L) ("LivaNova" or the "Company"), a market-leading medical technology company, announced today the launch of PLATINIUM, its ...

Itrevia HF-T QP boasts of latest defibrillator technology, closed loop stimulation and compatibility with a quadripolar lead, to help patients with heart failure conditions BIOTRONIK, a manufacturer ...

Report Ocean has published a new report on the Cardiac Resynchronization Therapy (CRT) Devices Market, delivering an extensive analysis of key factors such as market restraints, drivers, and ...

MINNEAPOLIS, USA and NICE, FRANCE - June 18, 2014 - New data from the Medtronic, Inc. (MDT) Adaptive CRT trial show a 61 percent (p=0.01) lower risk of atrial fibrillation (AF)-related problems in ...

INNOVATION PARTNER PROFILE/SISK HEALTHCARE:Sisk healthcare has announced a revolutionary medical device which will dramatically improve the lives of patients with heart problems AN INNOVATIVE NEW ...

Please provide your email address to receive an email when new articles are posted on . Among the features of the new European Society of Cardiology guideline on pacing and cardiac resynchronization ...

PLATINIUM, released simultaneously in both Europe and Japan by LivaNova (formerly Sorin Group), will protect patients from avoidable replacement surgeries and the inherent risk of complications.

The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT) showed a greater benefit with respect to mortality at 5 years among patients who received cardiac-resynchronization ...

The major trials that established cardiac resynchronization therapy (CRT) as a treatment for heart failure (HF) with reduced ejection fraction (HFrEF) tended not to include patients who already had ...

CHICAGO (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that shocks the ...

MARLBOROUGH, Mass., March 16, 2017 /PRNewswire/ -- Today, the National Institute for Health and Care Excellence (NICE) issued medical technology guidance recommending the use of Boston Scientific ...